A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Actinic Keratoses
Interventions
DRUG

PEP005

Trial Locations (9)

2010

Skin and Cancer Foundation, Darlinghurst

2217

St George Dermatology and Skin Cancer Centre, Level 3, 22 Belgrave St, Kogarah

4152

South East Dermatology, Belmont Specialist Centre, 1202 Creek Rd, Carina Heights

4217

The Skin Centre, Benowa

Unknown

Southderm Pty Ltd, Kogarah

Siller Medical, Brisbane

Auckland Dermatology, Epsom

Tristram Clinic, Hamilton

Skin Centre, Tauranga

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Peplin

INDUSTRY

NCT00427050 - A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel | Biotech Hunter | Biotech Hunter